fda glp-1 compounding Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide The Truth About Compounded GLP-1s
Description
Semaglutide weighs approximately 4,113 daltons, and tirzepatide weighs 5,808 daltonsboth positioned at or above the threshold where milk transfer becomes negligible
Overall, diabetics on GLP-1s increased 22% year over year from 2022 to 2023, while the number of diabetic members not taking GLP-1s has decreased
However, as of August 2025 , the FDA has approved Wegovy to treat fatty liver in certain people
doi: 10.1007/s10741-021-10200-y
doi: 10.3350/cmh.2025.0744, 51
